Research area · week to 3 Oct 2026

Pharmaceutical industry and healthcare

Moving in Annals of Internal Medicine, BMJ, JAMA, medRxiv, New England Journal of Medicine.

Moved this week: 0

Rebuilt 3 October 2026 at 5:53 pm AEST

Moved this week

Everything that moved →

Nothing in this area has moved yet this week.

Latest in Pharmaceutical industry and healthcare

Newest first · last 60 days

GMC right of appeal: prolonged proceedings put substantial financial burden on doctors.
BMJ · 17 Sept 2026 · Letter
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42754297
Open in JClub
Disclosure Without Context: The Case for More Transparent Clinical Practice Guidelines.
Annals of Internal Medicine · 15 Sept 2026 · Editorial
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42735409
Open in JClub
Assessing Front-of-Package Labels: The U.S. Food and Drug Administration's Proposed Rule in Context.
Annals of Internal Medicine · 1 Sept 2026 · Editorial
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42441968
Open in JClub
Patient-Centered Opioid Tapering: What Is It, and Does It Work?
Annals of Internal Medicine · 1 Sept 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42407066
Open in JClub
Self-Reported Side Effects Among Reddit Users Taking Nonapproved Retatrutide
medRxiv · 21 Aug 2026 · Preprint
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.05.28.26352819
Open in JClub
The Broader Dangers of Abandoning SGM Health Research.
New England Journal of Medicine · 20 Aug 2026 · Journal Article
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42612160
Open in JClub
Erosion of Professional Medical Standards by the Supreme Court.
JAMA · 11 Aug 2026 · Journal Article
Supreme Court decisions may undermine medical standards by protecting organizations providing substandard or unlicensed care that misleads patients.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42455594
Open in JClub

Follow this area in the app

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read

Moved this week

Latest in Pharmaceutical industry and healthcare

GMC right of appeal: prolonged proceedings put substantial financial burden on doctors.

Disclosure Without Context: The Case for More Transparent Clinical Practice Guidelines.

Assessing Front-of-Package Labels: The U.S. Food and Drug Administration's Proposed Rule in Context.

Patient-Centered Opioid Tapering: What Is It, and Does It Work?

Self-Reported Side Effects Among Reddit Users Taking Nonapproved Retatrutide

The Broader Dangers of Abandoning SGM Health Research.

Erosion of Professional Medical Standards by the Supreme Court.

Browse JClub